Find A PhysicianHome  |  Library  |  myDownstate  |  Newsroom  |  A-Z Guide  |  E-mail  |  Contact Us  |  Directions

SUNY Downstate Health Sciences University

Department of Dermatology

Clinical Trials

Recruiting now:

Prurigo Nodularis Study:

Eligibility: Must be ≥ 18 years with moderate to severe prurigo nodularis.

Study Procedures: An oral medication (Serlopitant) compared with placebo will be provided. The study will consist of 7 visits and 1 or 2 scheduled phone calls from the study site, for a total study period of 15 to 19 weeks. Blood draws are done at each visit. Compensation is provided.

Moderate to Severe Atopic Dermatitis Study:

Must be ≥ 12 years with moderate-to-severe atopic dermatitis and associated pruritus.  This is a phase 3 study prospective multicenter, open-label study to assess the long-term safety and efficacy of Nemolizumab (CD14152) in subjects ages 12 and older with moderate-to-severe atopic dermatitis and associated pruritus. Study medication (nemolizumab)  is an injectable. The study includes a 16-week initial treatment period, a 32 week maintenance period and an 8 week follow up period. Compensation will be provided  PI: Dr. Jakus

Pediatric Psoriasis Study: 

Must be age 6-17 years with moderate-to-severe plaque psoriasis. Thus is a phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of apremilast (CC-10004/Otezla) in pediatric subjects. Compensation will be provided. PI: Dr. Jakus

Vitiligo Study:

Must be ≥ 12 years. This is a phase 3, double-blind, randomized, vehicle-controlled, efficacy and safety study of topical ruxolitinib cream followed by an extension period in participants with vitiligo. Patients must have non-segmental vitiligo involving the face AND body. Compensation will be provided. PI: Dr. Jakus, Dr. Ast

Epidermolysis Bullosa Study: 

Must be ≥ 4 years with epidermolysis bullosa (DEB or JEB). A topical medication (0.03% RGN-137 Thymosin beta-4 gel) compared with placebo will be provided for daily use. The study will consist of 9 visits at the study site, for a total study period of 14 weeks. Compensation is provided. PI: Dr. Glick


We are recruiting patients for our active clinical trials. If you are interested in participating or obtaining more information, please contact our Dermatology Research Department at 718-270-2991.

Skin Condition Not Listed?

If you have a dermatological condition and would like to be considered for future studies, you are welcome to contact us, and we will add you to our database. We are always looking for patients with Eczema, Psoriasis, Acne, Lupus, skin infection, Hair and Nail conditions, and much more.

Contact Information:

For more information, please feel free to reach out to us. We are happy to answer any questions you may have. When emailing, please indicate the study title in the subject line: (ie. "PSORIASIS", "ACNE")

Jeannette Jakus, MD, MBA
Director Of Clinical Trials & Research:

Kristina Derrick MD, MSc
Pediatric Dermatology Research Fellow

Omobola Onikoyi DO, MSc
Dermatology Clinical Trials Research Fellow


Tel: 718-270-2991